Important note

This AI stock analysis for Clorox is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!


Clorox - AI Stock Analysis

Analysis generated September 1, 2024

Clorox is a well-established company specializing in household and cleaning products. The company operates in various segments including cleaning, household, lifestyle and international. Popular products over its portfolio include names like Clorox bleach, Pine-Sol and Fresh Step cat litter. Being a reputed name in the consumer goods sector, Clorox's performance often reflects consumer trends and economic conditions.

Fundamental Analysis

The fundamental analysis provides a deep insight into Clorox's financial health. For the last quarter, Clorox reported revenue of $1.97 billion. This marks a 10.05% increase from the previous quarter, a positive indication of growth. However, compared to the same quarter last year, there's a slight decrease of 0.71%. While the year-over-year decrease is minimal, it's essential to monitor if this turns into a consistent trend.

Net income for the last quarter was $216 million. Compared to the quarter before, this reflects a drastic 523.53% increase, which is an excellent indicator of short-term growth efficiency. On a year-over-year basis, the net income rose by 22.73%, reinforcing the positive growth trajectory.

However, a critical concern arises from the EBITDA, which was reported to be $0 for the last quarter. This represents a significant decrease of 100.00% compared to both the previous quarter and the same quarter last year. Such a drastic drop in EBITDA is alarming and may indicate severe issues in operational efficiency or extraordinary expenses.

The current Price to Earnings (P/E) ratio stands at 70.36, which can be considered high. A high P/E ratio often suggests that the stock might be overvalued, and investors should be cautious about this potential bearish signal.

Technical Analysis

Clorox's stock is currently priced at $158.31, which is a 19.01% increase compared to a month ago, signaling a very bullish short-term trend. Even over a year, the stock has recorded an increase of 5.58%, highlighting a positive long-term trend as well.

The Simple Moving Average (SMA) over 10 days is $155.84, slightly up from the previous SMA10 of $155.12. This trend suggests an upward momentum in the stock price. Furthermore, the Relative Strength Index (RSI) is 24.5, indicating that the stock might be in an oversold condition and predicting a potential bullish reversal.

Alternative Data Analysis

From an alternative data perspective, Clorox's business outlook among employees is neutral, offering no significant directional insight. The company estimates around 70,000 visitors to their webpage. However, this number is down by 42% in the last couple of months, which could indicate a reduction in customer interest or engagement. Such a substantial decrease is concerning for future revenue prospects.

Regarding customer engagement on social media, Clorox has 5,700 followers on Instagram and 3,700 on Twitter, with no notable changes recently. While the steady number of followers indicates consistent engagement, the lack of growth might imply stagnation in customer attraction efforts.

Lastly, the AltIndex AI score for Clorox stands at 35. This score, which consolidates various fundamental, technical, and alternative data indicators, signals a sell recommendation.

Conclusion and Recommendation

Based on the extensive analysis above, Clorox presents a mixed outlook. On the positive side, the company shows short-term revenue and net income growth, paired with a positive recent trend in the stock price. Conversely, the drastic decline in EBITDA and high P/E ratio poses significant concerns. The alternative data, particularly the decline in web visitors, suggests challenges in maintaining customer engagement.

Given these mixed signals, Clorox's stock appears to be somewhat overvalued, and the high P/E ratio and other concerns overshadow the short-term growth indicators. Consequently, while existing shareholders might consider holding onto their investments, potential new investors should approach Clorox stock with caution.

Overall, it's recommended to take a "Hold" or "Sell" position on Clorox, considering the high P/E ratio and slow growth in customer engagement metrics.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.